Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van de Sandt

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Basic Research in Cardiology|April 2, 2011
Desmoglein 2 mutant mice develop cardiac fibrosis and dilationClaudia A Krusche, Bastian Holthöfer, Valérie Hofe, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 14, 2010
The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and manJochem Louisse, Esther de Jong, Johannes J M van de Sandt, et al.
Basic Research in Cardiology|December 19, 2013
Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunctionMarc W Merx, Simone Gorressen, Annette M van de Sandt, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 30, 2009
Relative developmental toxicity of glycol ether alkoxy acid metabolites in the embryonic stem cell test as compared with the in vivo potency of their parent compoundsEsther de Jong, Jochem Louisse, Miriam Verwei, et al.
Regulatory Toxicology and Pharmacology : RTP|July 26, 2011
Evaluation of research activities and research needs to increase the impact and applicability of alternative testing strategies in risk assessment practiceAns Punt, Marie-Jeanne W A Schiffelers, G Jean Horbach, et al.
Plos One|April 16, 2015
Circulating NOS3 modulates left ventricular remodeling following reperfused myocardial infarctionSimone Gorressen, Manuel Stern, Annette M van de Sandt, et al.
The Journal of Nutrition|October 2, 2003
A pilot study to investigate effects of inulin on Caco-2 cells through in vitro metabolic fingerprintingRobert-Jan A N Lamers, Eveline C H H Wessels, Johannes J M van de Sandt, et al.
Cancer|April 15, 1993
Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosisP C de Bruin, A L Noorduyn, P van der Valk, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 12, 2008
Quercetin increases the bioavailability of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in ratsMaaike E Schutte, Gerrit M Alink, Andreas P Freidig, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 18, 2011
Patent ductus arteriosus in adults - indications and possibilities for closureF M van de Sandt, S M Boekholdt, B J Bouma, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Basic Research in Cardiology|April 2, 2011
Desmoglein 2 mutant mice develop cardiac fibrosis and dilationClaudia A Krusche, Bastian Holthöfer, Valérie Hofe, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 14, 2010
The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and manJochem Louisse, Esther de Jong, Johannes J M van de Sandt, et al.
Basic Research in Cardiology|December 19, 2013
Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunctionMarc W Merx, Simone Gorressen, Annette M van de Sandt, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 30, 2009
Relative developmental toxicity of glycol ether alkoxy acid metabolites in the embryonic stem cell test as compared with the in vivo potency of their parent compoundsEsther de Jong, Jochem Louisse, Miriam Verwei, et al.
Regulatory Toxicology and Pharmacology : RTP|July 26, 2011
Evaluation of research activities and research needs to increase the impact and applicability of alternative testing strategies in risk assessment practiceAns Punt, Marie-Jeanne W A Schiffelers, G Jean Horbach, et al.
Plos One|April 16, 2015
Circulating NOS3 modulates left ventricular remodeling following reperfused myocardial infarctionSimone Gorressen, Manuel Stern, Annette M van de Sandt, et al.
The Journal of Nutrition|October 2, 2003
A pilot study to investigate effects of inulin on Caco-2 cells through in vitro metabolic fingerprintingRobert-Jan A N Lamers, Eveline C H H Wessels, Johannes J M van de Sandt, et al.
Cancer|April 15, 1993
Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosisP C de Bruin, A L Noorduyn, P van der Valk, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 12, 2008
Quercetin increases the bioavailability of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in ratsMaaike E Schutte, Gerrit M Alink, Andreas P Freidig, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 18, 2011
Patent ductus arteriosus in adults - indications and possibilities for closureF M van de Sandt, S M Boekholdt, B J Bouma, et al.
Pageof 8